Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Share-based Compensation (2020 - 2026)

SkinHealth Systems has reported Share-based Compensation over the past 6 years, most recently at $3.6 million for Q4 2025.

  • Quarterly Share-based Compensation fell 38.72% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.8 million through Dec 2025, down 44.47% year-over-year, with the annual reading at $14.8 million for FY2025, 44.47% down from the prior year.
  • Share-based Compensation was $3.6 million for Q4 2025 at SkinHealth Systems, up from $2.5 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $8.5 million in Q2 2023 and troughed at $34000.0 in Q1 2021.
  • The 5-year median for Share-based Compensation is $5.6 million (2024), against an average of $5.2 million.
  • Year-over-year, Share-based Compensation skyrocketed 20632.35% in 2022 and then crashed 70.36% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $3.8 million in 2021, then soared by 100.82% to $7.6 million in 2022, then crashed by 70.36% to $2.3 million in 2023, then skyrocketed by 159.08% to $5.8 million in 2024, then crashed by 38.72% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Share-based Compensation are $3.6 million (Q4 2025), $2.5 million (Q3 2025), and $5.3 million (Q2 2025).